140 related articles for article (PubMed ID: 38169550)
1. The Therapeutic Efficacy of Zinc Oxide Nanoparticles on Acute Toxoplasmosis in BALB/c Mice.
Siahkal KR; Keshavarz H; Shojaee S; Mohebali M; Zeraati H; Azami SJ; Behkar A; Salimi M
Iran J Parasitol; 2023; 18(4):505-513. PubMed ID: 38169550
[TBL] [Abstract][Full Text] [Related]
2. Zinc oxide nanoparticles produced by Zingiber officinale ameliorates acute toxoplasmosis-induced pathological and biochemical alterations and reduced parasite burden in mice model.
El-Kady AM; S Hassan A; Mohamed K; Alfaifi MS; Elshazly H; Alamri ZZ; Wakid MH; Gattan HS; Altwaim SA; Al-Megrin WAI; Younis S
PLoS Negl Trop Dis; 2023 Jul; 17(7):e0011447. PubMed ID: 37410712
[TBL] [Abstract][Full Text] [Related]
3. Anti-
Teimouri A; Azami SJ; Keshavarz H; Esmaeili F; Alimi R; Mavi SA; Shojaee S
Int J Nanomedicine; 2018; 13():1341-1351. PubMed ID: 29563791
[TBL] [Abstract][Full Text] [Related]
4. Synthesis, characterization, and antiparasitic effects of zinc oxide nanoparticles-eugenol nanosuspension against
Cheraghipour K; Khudair Khalaf A; Moradpour K; Zivdari M; Beiranvand M; Shakib P; Mahmoudvand H; Marzban A
Heliyon; 2023 Aug; 9(8):e19295. PubMed ID: 37654466
[TBL] [Abstract][Full Text] [Related]
5. Zinc Oxide and Magnesium-Doped Zinc Oxide Nanoparticles Ameliorate Murine Chronic Toxoplasmosis.
Sarhan MH; Felemban SG; Alelwani W; Sharaf HM; Abd El-Latif YA; Elgazzar E; Kandil AM; Tellez-Isaias G; Mohamed AA
Pharmaceuticals (Basel); 2024 Jan; 17(1):. PubMed ID: 38256946
[No Abstract] [Full Text] [Related]
6. Effect of alginate nanoparticles on the immunogenicity of excretory-secretory antigens against acute toxoplasmosis in murine model.
Gaafar MR; El-Mansoury ST; Eissa MM; Shalaby TI; Younis LK; Rashed HA
Acta Trop; 2022 Jan; 225():106215. PubMed ID: 34687647
[TBL] [Abstract][Full Text] [Related]
7. Exploration of immunomodulatory and protective effect of Withania somnifera on trace metal oxide (zinc oxide nanoparticles) induced toxicity in Balb/c mice.
Kumar J; Mitra MD; Hussain A; Kaul G
Mol Biol Rep; 2019 Apr; 46(2):2447-2459. PubMed ID: 30847852
[TBL] [Abstract][Full Text] [Related]
8. In vitro and in vivo Anti-
Alnomasy SF
Infect Drug Resist; 2021; 14():5057-5068. PubMed ID: 34876824
[TBL] [Abstract][Full Text] [Related]
9. Successful treatment of acute experimental toxoplasmosis by spiramycin-loaded chitosan nanoparticles.
Hagras NA; Allam AF; Farag HF; Osman MM; Shalaby TI; Fawzy Hussein Mogahed NM; Tolba MM; Shehab AY
Exp Parasitol; 2019 Sep; 204():107717. PubMed ID: 31228418
[TBL] [Abstract][Full Text] [Related]
10. New life for an old drug: In vitro and in vivo effects of the anthelmintic drug niclosamide against Toxoplasma gondii RH strain.
Zhang JL; Si HF; Shang XF; Zhang XK; Li B; Zhou XZ; Zhang JY
Int J Parasitol Drugs Drug Resist; 2019 Apr; 9():27-34. PubMed ID: 30599391
[TBL] [Abstract][Full Text] [Related]
11. Promising
Esboei BR; Keighobadi M; Hezarjaribi HZ; Fakhar M; Daryani A; Chabra A; Soosaraei M; Yalveh R
Infect Disord Drug Targets; 2021; 21(1):151-155. PubMed ID: 32389115
[TBL] [Abstract][Full Text] [Related]
12. Anthelmintic and therapeutic effects of the biogenic zinc oxide nanoparticles against acute kidney injury induced by
Ali SB; Mohamed AS; Fahmy SR; El-Garhy M; Mousa MR; Abdel-Ghaffar F
J Parasit Dis; 2024 Mar; 48(1):14-24. PubMed ID: 38440749
[TBL] [Abstract][Full Text] [Related]
13. The role of
Ezzatkhah F; Mahmoudvand H; Raziani Y
Front Cell Infect Microbiol; 2023; 13():1161133. PubMed ID: 37249978
[TBL] [Abstract][Full Text] [Related]
14. Curcumin nanoemulsion as a novel chemical for the treatment of acute and chronic toxoplasmosis in mice.
Azami SJ; Teimouri A; Keshavarz H; Amani A; Esmaeili F; Hasanpour H; Elikaee S; Salehiniya H; Shojaee S
Int J Nanomedicine; 2018; 13():7363-7374. PubMed ID: 30519020
[TBL] [Abstract][Full Text] [Related]
15. Green synthesised zinc oxide nanoparticles reveal potent in vivo and in vitro antibacterial efficacy against Proteus mirabilis isolates.
Elekhnawy E; Almurshedi AS; Abdelkader DH; El-Masry TA; Aldosari BN; El-Bouseary MM; Donia AA; Negm WA
Int J Pharm; 2023 Jul; 642():123111. PubMed ID: 37302668
[TBL] [Abstract][Full Text] [Related]
16. Quantification of Toxoplasma gondii in the tissues of BALB/c mice after immunization with nanoliposomal excretory-secretory antigens using Real-Time PCR.
Azadi Y; Ahmadpour E; Hamishehkar H; Daryani A; Spotin A; Mahami-Oskouei M; Barac A; Rajabi S; Alizadeh P; Montazeri M
Comp Immunol Microbiol Infect Dis; 2018 Aug; 59():52-56. PubMed ID: 30290888
[TBL] [Abstract][Full Text] [Related]
17. Immunization with a DNA vaccine encoding Toxoplasma gondii Superoxide dismutase (TgSOD) induces partial immune protection against acute toxoplasmosis in BALB/c mice.
Liu Y; Cao A; Li Y; Li X; Cong H; He S; Zhou H
BMC Infect Dis; 2017 Jun; 17(1):403. PubMed ID: 28592247
[TBL] [Abstract][Full Text] [Related]
18. Intranasal immunisation with recombinant Toxoplasma gondii uridine phosphorylase confers resistance against acute toxoplasmosis in mice.
Yin LT; Ren YJ; You YJ; Yang Y; Wang ZX; Wang HL
Parasite; 2023; 30():46. PubMed ID: 37921620
[TBL] [Abstract][Full Text] [Related]
19. Behaviour of Toxoplasma gondii RH Ankara strain tachyzoites during continuous production in various cell lines.
Döskaya M; Degirmenci A; Ciçek C; Ak M; Korkmaz M; Gürüz Y; Uner A
Parasitology; 2006 Mar; 132(Pt 3):315-9. PubMed ID: 16318650
[TBL] [Abstract][Full Text] [Related]
20. Two old drugs, NVP-AEW541 and GSK-J4, repurposed against the Toxoplasma gondii RH strain.
Liu S; Wu M; Hua Q; Lu D; Tian Y; Yu H; Cheng L; Chen Y; Cao J; Hu X; Tan F
Parasit Vectors; 2020 May; 13(1):242. PubMed ID: 32393321
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
